Acro Biomedical (ACBM) Shareholder's Equity (QoQ) (2016 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | EQV Ventures Acquisition | 477.69 Mn | 477.69 Mn | - |
| 2 | Berto Acquisition | 316.66 Mn | 316.66 Mn | - |
| 3 | Centurion Acquisition | 311.94 Mn | 311.94 Mn | - |
| 4 | Churchill Capital Corp IX | 311.36 Mn | 311.36 Mn | - |
| 5 | Agriculture & Natural Solutions Acquisition | 301.94 Mn | 301.94 Mn | - |
| 6 | Siddhi Acquisition Corp (Cayman Islands) | 286.76 Mn | 286.76 Mn | - |
| 7 | Bold Eagle Acquisition | 276.06 Mn | 276.06 Mn | - |
| 8 | Cartesian Growth Corp III | 270.68 Mn | 270.68 Mn | - |
| 9 | Oyster Enterprises II Acquisition | 266.84 Mn | 266.84 Mn | - |
| 10 | Acro Biomedical | - | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 10.55% |
| Sep 30, 2025 | -36.25% |
| Jun 30, 2025 | -4.48% |
| Mar 31, 2025 | -3.03% |
| Dec 31, 2024 | -3.32% |
| Sep 30, 2024 | -3.29% |
| Jun 30, 2024 | -3.40% |
| Mar 31, 2024 | -4.01% |
| Dec 31, 2023 | -7.26% |
| Sep 30, 2023 | -170.55% |
| Jun 30, 2023 | -17.34% |
| Mar 31, 2023 | -15.52% |
| Dec 31, 2022 | -1.18% |
| Sep 30, 2022 | -14.39% |
| Jun 30, 2022 | -10.62% |
| Mar 31, 2022 | -0.08% |
| Dec 31, 2021 | 13.29% |
| Sep 30, 2021 | -11.24% |
| Jun 30, 2021 | 1.80% |
| Mar 31, 2021 | -8.31% |
| Dec 30, 2020 | -8.00% |
| Sep 30, 2020 | -8.76% |
| Jun 30, 2020 | -7.13% |
| Mar 31, 2020 | 10.22% |
| Dec 31, 2019 | -8.63% |
| Sep 30, 2019 | -7.84% |
| Jun 30, 2019 | -5.03% |
| Mar 31, 2019 | -14.53% |
| Dec 31, 2018 | -5.98% |
| Sep 30, 2018 | 59.80% |
| Jun 30, 2018 | 17.60% |
| Mar 31, 2018 | 11.74% |
| Dec 31, 2017 | 15.69% |
| Sep 30, 2017 | 1,915.55% |
| Jun 30, 2017 | -73.03% |
| Mar 31, 2017 | 26.70% |
| Dec 31, 2016 | -50.11% |
| Sep 30, 2016 | -70.70% |
| Jun 30, 2016 | -202.45% |